[Allelic imbalance in patients with non-small cell lung cancer].

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Arkhiv patologii

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 24006757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lung cancer in never smokers--a review.

  2012cited by this paper
• Genetic insight and therapeutic targets in squamous-cell lung cancer

  2012cited by this paper
• Genetic and epigenetic changes in lung carcinoma and their clinical implications

  2011cited by this paper
• Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion

  2009cited by this paper
• Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.

  2009cited by this paper
• Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas

  2008cited by this paper
• 3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer (NSCLC)

  2008cited by this paper
• Characterizing the cancer genome in lung adenocarcinoma

  2007cited by this paper
• Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival.

  2005cited by this paper
• Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium.

  2005cited by this paper
• Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer

  2005cited by this paper
• Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.

  2005cited by this paper
• Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.

  2005cited by this paper
• Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.

  2004cited by this paper
• Cytogenetics and molecular genetics of lung cancer.

  2002cited by this paper
• Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.

  2001cited by this paper
• Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.

  2001cited by this paper
• Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.

  2001cited by this paper
• Loss of heterozygosity is related to p53 mutations and smoking in lung cancer

  2001cited by this paper
• Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

  2000cited by this paper
• Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer.

  2000cited by this paper
• Loss of FHIT function in lung cancer and preinvasive bronchial lesions.

  1998cited by this paper
• Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.

  1996cited by this paper
• Molecular pathogenesis of lung cancer.

  1994cited by this paper
• Molecular genetics of lung cancer.

  1988cited by this paper

• The functional variant in promoter of OVCA1 was associated with the risk of gastric cancer in the northeast Chinese Han population.

  2021cites this paper
• ПОТЕРЯ ГЕТЕРОЗИГОТНОСТИ ЛОКУСОВ ГЕНОВ BRCA1 И BRCA2 В ОПУХОЛИ МОЛОЧНОЙ ЖЕЛЕЗЫ

  2020cites this paper
• LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER

  2020cites this paper
• Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients.

  2017cites this paper
• OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia

  2017cites this paper